Cordis acquires MedAlliance for USD 1.135 billion

Cordis, a US medical device company, acquired Swiss-based MedAlliance for USD 1.135 billion. MedAlliance develops the Sirolimus Drug-Eluting Balloon (Selution SLR) for stentless angioplasty.

“MedAlliance, a pioneer in drug device combinations, has harnessed innovation to provide a ground-breaking solution - the patented Sirolimus Drug Eluting Balloon, Selution SLR.”prnewswire.com

• 1 source
• prnewswire.comMedAlliance, a Pioneering Medical Device Startup, acquired by Cordis of USA in a Landmark USD 1.135 Billion DealMedAllianceOct 5, 2023

Summarized from public sources; check the original articles before acting on it.